CN1111426C - Diabetes treating medicine - Google Patents
Diabetes treating medicine Download PDFInfo
- Publication number
- CN1111426C CN1111426C CN00136251A CN00136251A CN1111426C CN 1111426 C CN1111426 C CN 1111426C CN 00136251 A CN00136251 A CN 00136251A CN 00136251 A CN00136251 A CN 00136251A CN 1111426 C CN1111426 C CN 1111426C
- Authority
- CN
- China
- Prior art keywords
- medicine
- diabetes
- fructus
- present
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese patent medicine for treating diabetes, which comprises Galla Chinensis, schisandra, mantis egg-case, ginseng, frankincense, myrrh, encommiae ulmoide, scrophularia, cornus, barbary wolfberry fruit and deerhorn glue. The medicine of the present invention has the advantages of nourishing yin and clearing heat, benefiting qi for promoting production of fluid, stimulating circulation to end stasis and reinforcing yang. The medicine of the present invention can effectively treat the diabetes.
Description
The present invention relates to a kind of medicine for the treatment of diabetes, is the Chinese patent medicine that is used for the treatment of diabetes specifically.
Diabetes are commonly encountered diseases and frequently-occurring diseases in the present worldwide, and sickness rate has the gesture of rising year by year, still do not have the radical cure method so far.Diabetic causes sugar, fat and proteinic metabolism disorder because insulin deficit, blood sugar increasing, and blood viscosity increases, and prolonged illness then causes the extensive microangiopathies of whole body, thereby on the optical fundus, positions such as cardiovascular and cerebrovascular vessel, kidney cause severe complication.
Doctor trained in Western medicine exists some defectives on the treatment diabetes at present.Biguanides, sulfonylureas drugs for diabetes side effect are big, and with producing antibody, curative effect descends insulin for a long time, and dosage is difficult for grasping simultaneously, might cause hypoglycemic reaction, and insulin injection also can bring pain to patient.Though the Chinese medicine of treatment diabetes is a lot of, fish eyes mixes, and person evident in efficacy is rarely seen.
The purpose of this invention is to provide a kind of lowering blood sugar and blood fat, microcirculation improvement, prevent and improve the medicine of the treatment diabetes of diabetic complication.
Diabetes belong to diabete in the traditional Chinese medical science, and diabete is an interior-heat caused by deficiency of YIN, and due to the YIN fluid deficiency, the deficiency of YIN then injures yang-energy for a long time, causes deficiency of both YIN and YANG, and deficiency of vital energy body fluid deficiency then hyperamization is become silted up.The Chinese medicine of in the past treating diabetes is paid attention to nourishing YIN and clearing away heat more and is promoted the production of body fluid, and seldom takes YANG invigorating into account, and many diabeticss, particularly prolonged illness, aged patient often have yang deficiency concurrently, and therefore YANG invigorating is not enough to effect a radical cure primary disease.Solution of the present invention has filtered out invigorating primordial QI at this, and the Chinese medicine of blood stasis is changed in the Tianjin of reinforcing the kidney, thereby activates pancreatic functions, promotes insulin secretion, improves and organizes microcirculation, and the generation of diabetes-alleviating complication makes blood glucose, and blood fat returns to normal level.
Medicine of the present invention is made by following component: (consumption is a weight portion)
Galla Chinensis 8-15 Fructus Schisandrae Chinensis 8-15 Ootheca Mantidis 8-15
Radix Ginseng 10-20 Olibanum 8-15 Myrrha 8-15
Cortex Eucommiae 10-30 Radix Scrophulariae 8-15 Fructus Corni 15-25
Fructus Lycii 10-30 Colla cornus cervi 15-25
The best proportioning of aforementioned pharmaceutical compositions is:
Galla Chinensis 10 Fructus Schisandrae Chinensis 10 Ootheca Mantidiss 10
Radix Ginseng 15 Olibanums 10 Myrrhas 10
The Cortex Eucommiae 20 Radix Scrophulariaes 10 Fructus Corni 20
Fructus Lycii 20 Colla cornus cervis 20
Aforementioned pharmaceutical compositions of the present invention is to form according to the theory of Chinese medical science prescription.Galla Chinensis wherein, Fructus Schisandrae Chinensis, Ootheca Mantidis, Radix Scrophulariae, Fructus Corni, the Fructus Lycii nourishing YIN is promoted the production of body fluid, ginseng qi-tonifying, Olibanum, Myrrha activating blood circulation to dissipate blood stasis, Colla cornus cervi, Cortex Eucommiae tonification Yuanyang.According to the pharmaceutical technology of routine, aforementioned pharmaceutical compositions can be prepared into any pharmaceutical dosage form that is suitable for using clinically, as pill, powder, capsule, tablet, oral liquid etc.
The method that said medicine is prepared into pill is: disposable powder is broken into powder, crosses 100 mesh sieves, becomes pill with processed with honey again.
Pharmaceutical preparation of the present invention is used for clinical practice, has obtained notable therapeutic effect.The characteristics of medicine of the present invention are not avoid sweet food during the treatment, though that blood glucose descends is comparatively slow, can reach the radical cure purpose.Drug treatment of the present invention is the pill administration of adopting pharmaceutical composition of the present invention to make, and 15 days was 1 course of treatment, generally kept 5-6 the course of treatment, blood glucose normally after, be interrupted after treatment several courses of treatment again up to the blood glucose long-term stability.Screen 100 routine patients and take this Drug therapy.Wherein 92 examples are the II diabetics, and all the other 8 examples are type i diabetes.Through treating 6 courses of treatment, 80 routine glucostasis are arranged among the II type patient below 130mg/L, all the other 12 routine patient's blood glucose have reduction in various degree, and clinical symptoms 100% has alleviation.I type patient blood glucose also all has decline, thirsty drink symptom is had to alleviate simultaneously.
Embodiment 1
Galla Chinensis 10g Fructus Schisandrae Chinensis 10g Ootheca Mantidis 10g
Radix Ginseng 15g Olibanum 10g Myrrha 10g
Cortex Eucommiae 20g Radix Scrophulariae 10g Fructus Corni 20g
Fructus Lycii 20g Colla cornus cervi 20g
With the oven dry of above-mentioned medical material, be ground into fine powder, cross 100 mesh sieves, become pill with processed with honey again, every ball 6g, or medicated powder incapsulated, every capsules contains medicated powder 1g.
Embodiment 2
Galla Chinensis 15g Fructus Schisandrae Chinensis 15g Ootheca Mantidis 15g
Radix Ginseng 20g Olibanum 15g Myrrha 15g
Cortex Eucommiae 25g Radix Scrophulariae 15g Fructus Corni 25g
Fructus Lycii 25g Colla cornus cervi 25g
Method for making is the same.
Embodiment 3
Galla Chinensis 8g Fructus Schisandrae Chinensis 8g Ootheca Mantidis 8g
Radix Ginseng 10g Olibanum 8g Myrrha 8g
Cortex Eucommiae 15g Radix Scrophulariae 8g Fructus Corni 15g
Fructus Lycii 15g Colla cornus cervi 15g
Method for making is with embodiment 1.
Model case
Li Jianyou, the man, 43 years old, type ii diabetes, myasthenia of limbs, vexed, blood glucose 8.5mmol/L, glucose in urine+, to take this medicine and treat six courses of treatment, blood glucose is reduced to 5.9mmol/L, and through keeping treatment, blood glucose still is stabilized in 5.9mmol/L after half a year, simultaneously spiritual amelioration.
Yang Yuzhen, the woman, 37 years old, dry mouth and tougue, hungry and can eat, the health inanition, limbs fatigue, xerosis cutis is drunk puzzledly yearningly, upsets two dryness and uneasy feeling of the eye.Survey blood glucose 14mmol/L, glucose in urine ++ ++.Take this medicine and treat six courses of treatment, blood glucose is reduced to 8.2mmol/L, glucose in urine+and, the while clinical symptom relief.
Claims (4)
1, a kind of pharmaceutical composition for the treatment of diabetes is characterized in that: it is the medicament of being made by following materials of weight proportions:
Galla Chinensis 8-15 Fructus Schisandrae Chinensis 8-15 Ootheca Mantidis 8-15
Radix Ginseng 10-20 Olibanum 8-15 Myrrha 8-15
Cortex Eucommiae 10-30 Radix Scrophulariae 8-15 Fructus Corni 15-25
Fructus Lycii 10-30 Colla cornus cervi 15-25.
2,, it is characterized in that the weight ratio of each component is according to the pharmaceutical composition of claim 1:
Galla Chinensis 10 Fructus Schisandrae Chinensis 10 Ootheca Mantidiss 10
Radix Ginseng 15 Olibanums 10 Myrrhas 10
The Cortex Eucommiae 20 Radix Scrophulariaes 10 Fructus Corni 20
Fructus Lycii 20 Colla cornus cervis 20
3, according to the pharmaceutical composition of claim 1, it is characterized in that: the dosage form of this medicine is that any pharmaceutically dosage form is learned upward said dosage form.
4, according to the pharmaceutical composition of claim 1, it is characterized in that: the dosage form of this medicine is a pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00136251A CN1111426C (en) | 2000-12-26 | 2000-12-26 | Diabetes treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00136251A CN1111426C (en) | 2000-12-26 | 2000-12-26 | Diabetes treating medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1299662A CN1299662A (en) | 2001-06-20 |
| CN1111426C true CN1111426C (en) | 2003-06-18 |
Family
ID=4597169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00136251A Expired - Fee Related CN1111426C (en) | 2000-12-26 | 2000-12-26 | Diabetes treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1111426C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943823A (en) * | 2016-05-24 | 2016-09-21 | 成都市斯贝佳科技有限公司 | Traditional Chinese medicine composition for treating diabetes |
-
2000
- 2000-12-26 CN CN00136251A patent/CN1111426C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1299662A (en) | 2001-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1108804C (en) | Diabetes treating medicine and its prepn. method | |
| CN1772261A (en) | Oral medicine for treafing eye inflammation, lession and hemorrhage and its prepn | |
| CN1111426C (en) | Diabetes treating medicine | |
| CN1742879A (en) | Chinese medicine for reducing blood sugar and preparation thereof | |
| CN1879783A (en) | A medicine for treating diabetes | |
| CN1101213C (en) | Diabetes treating medicine | |
| CN102114185B (en) | Medicament for treating insulin resistance of type 2 diabetes | |
| CN1748771A (en) | Chinese medicine composition for treating diabetes and its preparing method and use | |
| CN1272054C (en) | Medicine for treating diabetes and its preparing process | |
| CN1054524C (en) | Medicine composition for treating diabetes mellitus | |
| CN1186036C (en) | Diabetes treating medicine and its prepn | |
| CN1557301A (en) | Compositions for senile diabetes patient blood sugar and blood fat reduction | |
| CN1097333A (en) | A kind of pure plant health preparation glycolipid disappears and method for making | |
| CN1306830A (en) | Medicine for treating type II diabetes | |
| CN1183933C (en) | Medicine for treating incomplete kidney function and its prepn | |
| CN1289609A (en) | Chinese patent medicine (Tangweiping) for treating eyeground affection of diabetes | |
| CN1291722C (en) | Use of oligoxylose in preparing medicine for treating diabetes | |
| CN1209125C (en) | Diabetes treating medicine | |
| CN1292765C (en) | Pharmaceutical composition, its preparation process and usage | |
| CN1435209A (en) | Medicine for treating biabetes and preparing process thereof | |
| CN1657050A (en) | Chinese medicine oral preparation for lonering blood sugar and its preparation method | |
| CN1425412A (en) | Compound oral thrombolytic preparation and its preparing method | |
| CN101036714A (en) | Medicinal composition for treating and/or preventing diabetes | |
| CN1129448C (en) | Chinese medicine bolus for treating cataract | |
| CN1239179C (en) | Chinese medicine for treating diabetes and preparation method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1041807 Country of ref document: HK |